Zenotech Laboratories ROE

Mitä Zenotech Laboratories tekee? Zenotech Laboratories Ltd, listed on the Bombay Stock Exchange with ticker 532039.BO and ISIN INE486F01012, is a biotechnology company operating in the healthcare sector. Headquartered in Hyderabad, India, the company employs 150 full-time staff. Founded through an IPO on May 14, 1996, Zenotech focuses on the manufacturing and marketing of pharmaceutical products, specifically specializing in specialty generic injectables. Its production facilities are located in Turkapally village, Shamirpet Mandal, Telangana. The company's product portfolio includes oncology, biotechnology, and general injectables. Zenotech Laboratories Ltd maintains a website at http://zenotechlab.com/ for further information. The firm's operations are centered around the development and distribution of injectable pharmaceutical solutions, targeting both domestic and international markets. With its focus on injectables, the company aims to provide accessible and reliable healthcare products. The company's headquarters in Hyderabad serves as the central hub for its business activities, including research, development, and administrative functions. Zenotech's business model emphasizes the production of generic injectables, which are critical for various medical treatments, particularly in oncology and biotechnology sectors. The company's presence in the Telangana region, with its manufacturing facility in Turkapally, underscores its commitment to local manufacturing and supply chain efficiency. As a publicly traded entity, Zenotech Laboratories Ltd. provides investors with exposure to the biotechnology and pharmaceutical sectors within India's healthcare industry. Zenotech Laboratories on yksi Eurpooliin suosituimmista yhtiöistä.